We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
-6.47%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14.1B
AUM Growth
-$2.27B
(-14%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
310
New
28
Increased
101
Reduced
110
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$225M |
| 2 |
Lowe's Companies
LOW
|
+$182M |
| 3 |
Yum! Brands
YUM
|
+$171M |
| 4 |
Amazon
AMZN
|
+$143M |
| 5 |
Steris
STE
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$253M |
| 2 |
Citigroup
C
|
+$243M |
| 3 |
Viatris
VTRS
|
+$151M |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$150M |
| 5 |
Whirlpool
WHR
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Consumer Discretionary | 17.52% |
| 3 | Technology | 15.79% |
| 4 | Industrials | 11.57% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
101
DELISTED
MEDIVATION, INC.
MDVN
| $45.7M | 0.32% |
1,075,846
+212,240
| +25% | +$10.5M |
|
|
KNL
102
DELISTED
Knoll, Inc.
KNL
| $45.7M | 0.32% |
2,079,962
+68,775
| +3% | +$1.65M |
|
103
Avient
AVNT
$3.94B
| $45.6M | 0.32% |
1,554,081
+146,505
| +10% | +$4.95M |
|
104
Neurocrine Biosciences
NBIX
$16.2B
| $45.6M | 0.32% |
1,145,845
-27,595
| -2% | -$1.33M |
|
105
Prothena Corp
PRTA
$443M
| $44.8M | 0.32% |
987,979
-404,871
| -29% | -$23.6M |
|
106
Nexstar Media Group
NXST
$5.95B
| $43.9M | 0.31% |
928,083
+29,655
| +3% | +$1.5M |
|
107
Asbury Automotive
ABG
$3.94B
| $43.9M | 0.31% |
540,748
+113,375
| +27% | +$9.6M |
|
108
Unum
UNM
$14.2B
| $42.6M | 0.3% |
1,328,905
-14,865
| -1% | -$512K |
|
109
Williams-Sonoma
WSM
$29.3B
| $40.8M | 0.29% |
1,069,518
+32,610
| +3% | +$1.33M |
|
110
Jones Lang LaSalle
JLL
$16.9B
| $40.8M | 0.29% |
283,670
+8,447
| +3% | +$1.38M |
|
111
Bright Horizons
BFAM
$3.91B
| $40.6M | 0.29% |
632,115
+74,495
| +13% | +$4.6M |
|
|
IM
112
DELISTED
Ingram Micro
IM
| $38.3M | 0.27% |
1,405,131
-3,915
| -0.3% | -$102K |
|
|
PAY
113
DELISTED
Verifone Systems Inc
PAY
| $38M | 0.27% |
1,371,090
-646,271
| -32% | -$20.2M |
|
114
Watsco Inc
WSO
$13.6B
| $37.7M | 0.27% |
318,190
-11,100
| -3% | -$1.38M |
|
115
Expedia Group
EXPE
$37.4B
| $37.1M | 0.26% |
315,293
+34,398
| +12% | +$3.96M |
|
116
Dentsply Sirona
XRAY
$2.75B
| $36.4M | 0.26% |
719,702
+100,227
| +16% | +$5.34M |
|
117
Robert Half
RHI
$4.19B
| $36.2M | 0.26% |
706,879
-108,195
| -13% | -$5.82M |
|
118
Quest Diagnostics
DGX
$26.1B
| $36.1M | 0.26% |
586,573
-9,581
| -2% | -$670K |
|
|
HOT
119
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $35.4M | 0.25% |
532,666
+263,920
| +98% | +$20.1M |
|
120
Ameriprise Financial
AMP
$49.4B
| $35M | 0.25% |
320,575
+53,075
| +20% | +$6.26M |
|
|
SCS
121
DELISTED
Steelcase
SCS
| $34.6M | 0.24% |
1,877,299
+259,416
| +16% | +$4.65M |
|
|
EFII
122
DELISTED
Electronics for Imaging
EFII
| $33.5M | 0.24% |
773,630
+110,335
| +17% | +$4.9M |
|
123
PTC Therapeutics
PTCT
$5.87B
| $33.4M | 0.24% |
1,251,141
-1,215,619
| -49% | -$52M |
|
|
MXIM
124
DELISTED
Maxim Integrated Products
MXIM
| $33.4M | 0.24% |
998,925
+347,435
| +53% | +$11.5M |
|
|
ALEX
125
DELISTED
Alexander & Baldwin
ALEX
| $32.9M | 0.23% |
959,325
+31,445
| +3% | +$1.15M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Westfield Capital Management held 310 positions worth $14.1B, down 14% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management withdrew a net $900M in Q3 2015, closing 49 positions and reducing 110 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $150M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Westfield Capital Management opened a new position in Lowe's Companies worth $182M.
- Westfield Capital Management's largest Q3 2015 buy was Lowe's Companies: 2,647,293 shares worth $182M.
- Westfield Capital Management added most to Vertex Pharmaceuticals in Q3 2015, an estimated $225M increase.
- Westfield Capital Management's biggest Q3 2015 reduction was Allergan plc, cutting an estimated $253M.
- Westfield Capital Management fully exited PRECISION CASTPARTS CORP in Q3 2015, selling an estimated $150M.
- Westfield Capital Management's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2015.
- Westfield Capital Management opened 28 new positions and closed 49 in Q3 2015.
- Westfield Capital Management's portfolio value fell 14% quarter-over-quarter to $14.1B.
Based on Westfield Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.